PharmaCyte Biotech Inc (PMCB) Peer Comparison

$0.54

$0.00 (-0.06%)

As on 27-Aug-2026 16:00EDT

Market cap

$6 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Edit

	PharmaCyte Biotech Inc (PMCB)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Market cap ($ Mln)	6	666	53,134
Revenue ($ Mln)	--	915	254,248
Net Profit ($ Mln)	-19.42	-122.57	1,714.00
Net Margin (%)	--	-12.90	0.67
RoE (%)	-45.61	-6.65	-60.52
Price to Earnings	--	--	32.45
Price-To-Book	0.16	0.41	16.07

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	PharmaCyte Biotech Inc (PMCB)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Operating Revenue	0.00	915.45	254,248.00
Cost of Revenue	--	655.01	244,474.00
Gross Profit	--	260.44	9,774.00
Operating Expenses	6.85	323.47	7,161.00
Operating Profit (EBIT)	-6.85	-63.03	2,613.00
Other Income	--	--	--
Profit before Tax	-19.42	-88.06	2,174.00
Provision for Tax	--	17.10	469.00
Profit after Tax (Net Income)	-19.42	-122.57	1,714.00
Minority Interest	--	--	--
Consolidated Profit	--	--	--

Liabilities ($ Mln)

	PharmaCyte Biotech Inc (PMCB)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Shareholder's Funds	33.29	1,614.33	-2,883.00
Minority Interest	--	--	--
Non-Current Liabilities	9.26	374.77	16,119.00
Current Liabilities	0.83	358.38	43,904.00
Total Liabilities	46.75	2,328.01	57,299.00

Assets ($ Mln)

	PharmaCyte Biotech Inc (PMCB)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Non-Current Assets	9.33	1,535.88	18,546.00
Current Assets	37.42	792.13	38,753.00
Total Assets	46.75	2,328.01	57,299.00
Total Debt*	--	398.40	9,948.00
Net Current Assets	36.59	433.75	--

Cashflow ($ Mln)

	PharmaCyte Biotech Inc (PMCB)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Cash From Operating Activities	-5.15	-69.14	5,174.00
Cash Flow from Investing Activities	2.00	-55.80	-2,584.00
Cash from Financing Activities	6.58	130.99	-1,602.00
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	PharmaCyte Biotech Inc (PMCB)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
ROCE (%)	-45.61	-5.40	25.15
ROE (%)	-45.61	-6.65	-60.52
ROA (%)	-38.12	-4.68	3.10
EBIT Margin (%)	--	--	--
Net Margin (%)	--	-13.39	0.67
Cash Profit Margin (%)	--	--	--

Growth Ratios

	PharmaCyte Biotech Inc (PMCB)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Revenue Growth (%)	--	-0.19	0.14
EBIT Growth (%)	--	--	--
Net Profit Growth (%)	-163.36	95.92	9.80
EPS Growth (%)	--	--	0.11
Book Value Growth (%)	--	--	--

Valuation Ratios

	PharmaCyte Biotech Inc (PMCB)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Price / Earnings	--	--	32.85
Price / Book Value	--	--	-19.53
Dividend Yield (%)	--	--	--
EV/EBITDA	6.99	-4.33	17.65
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	PharmaCyte Biotech Inc (PMCB)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Debt to Equity	--	0.25	-3.45
Short term debt to equity ratio	--	0.02	-0.72
Current Ratio	45.28	2.21	0.88
Quick Ratio	--	1.37	0.49
Interest Coverage	--	-1.94	7.25

Operating Efficiency Ratios

	PharmaCyte Biotech Inc (PMCB)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Debtors to sales (%)	--	20.66	5.43
Asset Turnover	0.00	0.35	4.61
Receivable days	--	70.99	19.43
Inventory Days	--	187.61	25.49
Payable days	--	129.76	54.53
Cash Conversion Cycle	--	128.85	-9.60

Annual
Quarterly